QGEN241220P22500
- 0.00
- 0.000.00%
Qiagen NV Newsroom
Qiagen Plans to Open New Facility in Spain in 2026
QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing
QIAGEN Launches Novel Tools for Customizing Digital PCR Assays and NGS Panels for Microbial Analysis
Qiagen N.V.'s (NYSE:QGEN) Intrinsic Value Is Potentially 43% Above Its Share Price
Innovations Support QIAGEN Shares Despite Macroeconomic Concerns
Morgan Stanley Lists Hedge Funds' Largest Q3 Ownership Increases in Russell 1000 Stocks
Syros Pharmaceuticals Gave Notice To Qiagen Manchester Limited Of Its Election To Terminate The Master Collaboration Agreement Dated March 7, 2022
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
QGEN Collaborates With McGill University Centre: Stock to Gain?
QIAGEN Collaborates With McGill University to Advance Microbiome Research
UBS Maintains Qiagen NV(QGEN.US) With Hold Rating
These 4 Measures Indicate That Qiagen (NYSE:QGEN) Is Using Debt Safely
Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting)
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45
Qiagen (QGEN) Receives a Hold From Stifel Nicolaus
TD Cowen Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $49
Express News | Qiagen NV : Morgan Stanley Raises Target Price to $50 From $49
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation?
Deutsche Bank Maintains Qiagen NV(QGEN.US) With Buy Rating
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up